+8613480855800
Ewaka / Amawulire / Okwesiima

Jul 30, 2025

Lwaki coriolus versicolor butto ayitibwa ‘Nature’s Master Immune modulator’? Okwekenenya kwa sayansi ku nkola yaayo ey’okulwanyisa kookolo ey’emirundi ebiri n’ekibumba-enkola y’okukuuma .

Ebyama by'okukyusakyusa obusimu bw'omubiri obuziyiza endwadde mu Coriolus Versicolor .

Coriolus versicolor butto ava mu mibiri gy’ebibala egy’enseenene eno etali ya bulijjo ey’eddagala. Okunoonyereza okw’omulembe kulaga nti erimu eby’enjawulo .Ebirungo ebiyitibwa polysaccharide peptides (PSP) .nePolysaccharides (PSK) .Ebizibu. Ebitundu bino ebikola bikola bitya okuyita mu nkola za multi-Target mechanisms okukola nga byombi "Cancer Guardian" ne "Liver Protector"?

Ebitundu ebikulu ebikola n’enkola .

Peptide ya polysaccharide (PSP) .

immune sentinel okukola .: eyongera okukula kw’obutoffaali bwa dendritic 3× n’obulungi bw’okulaga antigen ebitundu 50% .

Anticancer Synergy .: Enhances PD-1 inhibitor effects (35% okweyongera mu kigero ky’okukendeera kw’ekizimba) .

Obukuumi bw’obusannyalazo .: Akendeeza ku post-Radiotherapy lymphocyte apoptosis (60% protection rate)

 

Polysaccharide (PSK) .

Okuziyiza ekizimba obutereevu .: Eziyiza obutoffaali bw’ekizimba MMP-2/9 okufulumya (okukendeera 70% mu busobozi bw’okusaasaana) .

Okuzza obuggya obutoffaali bw’ekibumba .: Asitula okufulumya ensonga y’okukula kw’ekibumba (40% amangu okusaasaana) .

Okuziyiza akawuka .: Eziyiza okusiba akawuka ka siriimu ku bikwata ku CD4 (IC50=12UG/ML) .

 

Ebirungo ebiyitibwa triterpenoids .

Chemo-Okuggya obutwa mu mubiri .: Akendeeza ku cisplatin-okwonooneka kw’ekibumba okuleetebwa (45% okukendeera mu serum creatinine) .

Okulongoosa mu ntuuyo .: kyongera ebitundu bya asidi wa bile eby’omugaso (2× ebisinga obungi mu UDCA) .

Obukuumi bwa mitochondrial .: Ekuuma emitendera gya ATP egy'ekibumba 80% wansi w'obutaba na mukka gwa hypoxia .

Emigaso egyakakasibwa mu bujjanjabi .

Okujjanjaba kookolo .

Agaziya obulamu obw’omu makkati mu kookolo w’olubuto n’emyezi 8.5 (Phase III Trial) .

Okukendeera kwa 55% mu buwuka obuyitibwa radiation-Obulwadde bw'omu kamwa obuleetebwa .

Enzirukanya y’obulwadde bw’ekibumba .

2-3log okukendeeza ku HBV DNA viral load (omusomo gwa wiiki 48) .

35% Okulongoosa mu bubonero bw'ekibumba ekitamiivu ekitamiivu .

Okuddamu okukola abaserikale b’omubiri .

60% Faster Cd4+ Okuddamu okukola kw'obutoffaali -Eddagala eriweweeza ku butoffaali .

40% low infection rate oluvannyuma lw’okusimbuliza obusimu bw’amagumba .

Okuzimba okutambula obutasalako .

68% okusonyiyibwa mu ulcerative colitis .

25% Okukendeeza ku nsonga y’endwadde z’ekiwanga .

Protocol y'okukozesa obulungi .

Okusaba

Enkola Ennungamu .

Omukozi w’emirimu .

Dozi ya buli lunaku .

Enzirukanya y’obujjanjabi .

Kookolo Adjunct .

Ekirungo kya PSP .

CD83+ Obutoffaali bwa DC .

1-2g

Concurrent ne chemo/radiation .

Obuwagizi bw'ekibumba .

Obuwunga obujjuvu-obuwunga bwa spectrum .

ALT/AST .

3-5g

Emyezi 3-6 .

Modulation y’abaserikale b’omubiri .

Ebikuta bya PSK .

Enkola y’obutoffaali bwa NK .

500mg .

Okukozesa okutasalako .

Enkola z’okugatta ssaayansi .

nga mulimu selenium .: Ayongera ku glutathione peroxidase (GPX) emirimu gya 30% .

Nga mulimu ekirungo kya Boswellia .: NF bbiri -κB/cox-2 okuziyiza (2.3× anti-inflammatory effect) .

nga zirina ebirungo ebiyamba okuzimba omubiri (probiotics) .: Alongoosa chemo-ekiddukano ekikwatagana (50% higher efficacy) .

Okwegendereza okw’enjawulo .

Ekikolwa ky'eddirisa eky'obujjanjabi .: Okusukka 5g/olunaku kiyinza okuleeta okunyigirizibwa kw’obusimu (kyetaagisa okulabirirwa) .
Emitendera gy’okulongoosa .: okulekera awo wiiki 2 pre-op (okuvaamu omusaayi) .
Endwadde z'obusimu obuziyiza endwadde .: Yeetaaga okulondoola obusimu obuziyiza endwadde obw'okumpi .

Omutindo gwa zaabu ogw’omutindo .

1 Okuggya omubiri ebibala (si mycelium) .
5 Tekinologiya w'okuzikiririzaamu emirundi ebiri{{0}
3 Okugezesa ebyuma ebizito (PB .<0.5ppm)

Obujulizi bw'abakozesa .

"Emitendera gya AFP egy'enkalakkalira oluvannyuma lw'obujjanjabi obw'okuyingira mu nsonga z'ekibumba" - 52M (n'obujjanjabi obwa bulijjo)
"Cronic HBV carrier finally etuuse ku secoclearance" - 38F (egattibwa wamu ne antivirals)

Mechanistic breakthroughs .

Modulation y'ekifo eky'okukebera abaserikale b'omubiri .(2023 Okuzuula):

Yongera ekizimba-Obutoffaali bwa T obuyingira8+ (2.3×) .

Akendeeza ku kitundu kya Treg (25%→12%) .

 

Gut-Etteeka ly’ekisiki ky’ekiwuka .:

Ayongera ku butyrate-afulumya obuwuka (Faelibacterium 3.5×) .

Akendeeza ku bungi bw’eddagala eriweweeza ku bulwadde bwa siriimu (42%) .

Kiki ekifuula Coriolus okuba ow’enjawulo?
Bw’ogeraageranya n’eddagala eriweweeza ku kookolo eritali limu-erimu eddagala eriweweeza ku kookolo, liwa:

Dual immune modulation n'okukola obutereevu okulwanyisa ekizimba .

Okukuuma ebitundu by’omubiri nga kugatta wamu n’okutumbula obujjanjabi .

Okukakasa okw'omulembe okw'ennono "fu zheng que xie" endowooza .

Oyinza n'okwagala .

Weereza obubaka .